Shanghai RAAS surpasses 1% share repurchase target

Shanghai RAAS Blood Products Co., Ltd. announced that as of August 29, 2025, it had cumulatively repurchased 68,321,952 shares, representing 1.03% of the company's total share capital. The repurchases were conducted through centralized bidding via a dedicated securities account. The total transaction amount for these repurchases reached CNY 469,849,037.98, excluding trading commissions and other fees. The highest price paid per share was CNY 7.09, while the lowest was CNY 6.62.

The company's board of directors approved the share repurchase plan on January 13, 2025, with shareholder approval granted on February 14, 2025. The plan aims to repurchase shares with a total value of no less than CNY 250 million and no more than CNY 500 million, at a price not exceeding CNY 9.55 per share. These repurchased shares are intended for employee stock ownership plans or equity incentives. The repurchase period is set for 12 months from the date of shareholder approval.

The company initiated its first share repurchase on April 2, 2025. Shanghai RAAS confirmed that the repurchase activities comply with its approved repurchase plan and relevant laws and regulations. The company will continue to implement the repurchase plan and provide timely disclosures.